
THANZ HSANZ Webinar: “COBRRA-Comparison of Bleeding Risk between Rivaroxaban and Apixaban”
Featured speakers inlcude
- A/Prof Vivien Chen (Concord Hospital, University of Sydney, NSW) – “The COBRRA Study”
- Dr Dani Robinson (Alfred Health, Vic) – “VTE Management in 2026: Key Updates and Clinical Implications”
- Dr Kirollos Kamel (Townsville Hospital, Qld) – “DOACs in the Coagulation Laboratory”
The webinar will cover the recently published COBRRA study, the new VTE guidelines and DOAC testing in the lab.
Attendance is free and open to all, but you must register. Registrations will open in mid- June






